Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179764 · ClinicalTrials.gov registry record · NA
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT00179764 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 68 participants.
The verdict
NCT00179764, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effectiveness of transplantation of high doses of peripheral blood stem cells (stem cells are special cells found in the blood and bone marrow that produce new blood cells) after treatment with non-myeloablative chemotherapy (not toxic to the bone marrow). In addition, this study will assess the side effects of the transplant.
Interventions
- PROCEDURE Immunoablative Hematopoietic PBSC Transplant
- PROCEDURE Busulfan pharmacokinetics
- RADIATION Central Nervous System (CNS) prophylaxis radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2000-03-10 |
| Est. Completion | 2014-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179764
The ClinicalTrials.gov registry entry for NCT00179764 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Immunoablative Hematopoietic PBSC Transplant is the first listed.
NCT00179764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179764 about?
NCT00179764 is a clinical study titled "Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])". The purpose of this research study is to evaluate the effectiveness of transplantation of high doses of peripheral blood stem cells (stem cells are special cells found in the blood and bone marrow that produce new blood cells) after treatment with non-myeloablative chemotherapy (not toxic to the bon...
What is the current status of trial NCT00179764?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2000-03-10. Estimated completion is 2014-01-24.
What interventions are being tested in trial NCT00179764?
The interventions under investigation include: Immunoablative Hematopoietic PBSC Transplant (PROCEDURE), Busulfan pharmacokinetics (PROCEDURE), Central Nervous System (CNS) prophylaxis radiation (RADIATION).
Who is sponsoring clinical trial NCT00179764?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.